Manulife Investments Targets Under-researched Singapore Small and MidCaps With New Income Strategy
Strategy developed under MAS EQDP to capture under-researched opportunities in Singapore equitiesSINGAPORE,…
3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
MEXC Launches Commodity Zero-Fee Gala with $1 Million in Trading Rewards
VICTORIA, Seychelles, March 2, 2026 /PRNewswire/ -- MEXC, the world's fastest-growing digital…
KuCoin Enhances Lite Mode With Earn and Feed, Supporting Confident Entry Into Crypto and Broader Adoption
PROVIDENCIALES, Turks and Caicos Islands, March 2, 2026 /PRNewswire/ -- KuCoin, a leading…
BRITISH ROYAL MINT CELEBRATES 30 YEARS OF GIRL POWER WITH OFFICIAL SPICE GIRLS COMMEMORATIVE COIN
LLANTRISANT, Wales, March 2, 2026 /PRNewswire/ -- If you really really really wanna…
Starlight Investments Expands Asia-Pacific Presence with Senior Hire in Korea
Starlight appoints TK Gong as Vice President, Global Markets, Asia and the Pacific and opens…
Pediatric Home Service Partners with Morgans to Expand Prescribed Pediatric Extended Care Services in Texas with New Center, Morgans Wonder Care
SAN ANTONIO, March 02, 2026 (GLOBE NEWSWIRE) -- Pediatric Home Service (PHS),…
HONOR Advances Its AI Vision at MWC 2026 with Robot Phone, Humanoid Robot and Magic V6
From robotics innovation to flagship devices, HONOR expands its AI device ecosystem…
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142)…
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease
March 01, 2026 09:45 ET | Source: Celldex Therapeutics, Inc. - Late…
